WHO ICTRP trial
The efficacy of Jazar capsule, on menopausal symptoms and sexual disorder of…
IRCT20180705040349N1 · Iranian Registry of Clinical Trials (IRCT) · Recruiting
Key facts
| Trial ID | IRCT20180705040349N1 |
|---|---|
| Public title | The efficacy of Jazar capsule, on menopausal symptoms and sexual disorder of menopausal women |
| Scientific title | The efficacy of Jazar capsule, a Persian medicine product, on menopausal symptoms and sexual disorder of menopausal women |
| Primary sponsor | Tehran University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Recruiting |
| Study type | interventional |
| Phase | 3 |
| Countries | Iran (Islamic Republic of) |
| Conditions | Menopausal symptoms and sexual disorder of menopausal women. Menopausal and female climacteric states |
| Interventions | Intervention 1: Intervention group: Jazar capsule 500mg, made by Talaye sabz Tooba company, Including powder of chastetree seeds, fennel seeds and carrot seeds, two capsules in the morning and two at night, after meals, for 8 weeks… |
| Registration date | Oct 9, 2018 |
| Target size | 90 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: